New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 30, 2014
07:08 EDTINSYInsys backs Q2 revenue view of over $52M, consensus $52.77M
Insys Therapeutics reaffirmed its revenue guidance for Q2 ended June 30. Revenue from sales of Subsys is expected to exceed $52M for the quarter, as compared with $18.5M during 2Q13.
News For INSY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
08:30 EDTINSYInsys Therapeutics price target raised to $65 from $57 at RBC Capital
Subscribe for More Information
March 3, 2015
07:09 EDTINSYInsys Therapeutics reports Q4 adjusted EPS 53c, consensus 44c
Reports Q4 revenue $66.5M, consensus $63.45M.
February 26, 2015
07:20 EDTINSYInsys Therapeutics cannabidiol receives fast track designation From FDA
Subscribe for More Information
February 24, 2015
07:07 EDTINSYInsys Therapeutics in-licenses novel mast cell therapy for chronic pelvic pain
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use